Undiagnosed sleep apnea is a major comorbidity of CVD and a significant risk factor for stroke, CAD, CHF and AFib3. Sleep apnea puts an enormous strain on the heart and remodels the cardiac substrate through stretching, oxidative stress and frequent sympathetic surges4.
Screening all patients, new (undiagnosed) and existing (under-titrated CPAP), was reported to improve patient outcomes and have a 42% relative risk reduction in AFib recurrence6-7 and a 38% risk reduction in CVD mortality8. A simple yes/no questionnaire called STOP-BANG takes just a few minutes and indicates a high probability of obstructive sleep apnea.
Optimized Sleep Apnea Management via home sleep test equipment may improve cardiovascular treatment results8.
Total Sleep Solutions is a novel cross-disciplinary model of care developed in collaboration with cardiologists, sleep physicians and industry partners for the management of cardiac patients.
It expands the reach of sleep services by enabling point of care variability, providing a scalable model for management of a massive volume of patients’ while reducing wait times and overall cost, and offering optimized IT systems and human field resources to support the vast underdiagnosed pool of cardiac patients suffering from the co-morbidity of Sleep Apnea.